Submitted by Anonymous (not verified) on 24 April 2024 - 8:41
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Status: Opinion
Source:
Human medicines European public assessment report (EPAR): Fruzaqla, fruquintinib, Status: Opinion